Conference icon

Conference

CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL

Publication status:
Published

Actions


Authors


Expand authors...
Volume:
23
Pages:
181-182
Publication date:
2012-09-05
ISSN:
0923-7534
URN:
uuid:dca8e578-1bad-41f6-8c91-e10930a0cc60
Source identifiers:
364260
Local pid:
pubs:364260

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP